Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Method for identifying type I diabetes mellitus in humans

Patent ·
OSTI ID:1016737
 [1];  [2];  [3];  [2]
  1. Kennewick, WA
  2. Richland, WA
  3. Pasco, WA
+ Show Author Affiliations

A method and system for classifying subject populations utilizing predictive and diagnostic biomarkers for type I diabetes mellitus. The method including determining the levels of a variety of markers within the serum or plasma of a target organism and correlating this level to general populations as a screen for predisposition or progressive monitoring of disease presence or predisposition.

Research Organization:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
Sponsoring Organization:
USDOE
Assignee:
Battelle Memorial Institute (Richland, WA)
Patent Number(s):
7,923,253
Application Number:
US Patent Application 12/291,173
OSTI ID:
1016737
Country of Publication:
United States
Language:
English

References (2)

Salivary protein profiling in type I diabetes using two-dimensional electrophoresis and mass spectrometry journal March 2006
Increased plasma corticosteroid-binding globulin in insulin-dependent pubertal diabetics: Relationships with other glycoproteins, growth hormone and prolactin journal October 1979

Similar Records

Peptide and protein biomarkers for type 1 diabetes mellitus
Patent · Tue Aug 30 00:00:00 EDT 2016 · OSTI ID:1311866
Peptide and protein biomarkers for type 1 diabetes mellitus
Patent · Tue Jun 10 00:00:00 EDT 2014 · OSTI ID:1134213
Serum markers for type II diabetes mellitus
Patent · Tue Mar 18 00:00:00 EDT 2014 · OSTI ID:1127136

Related Subjects

60 APPLIED LIFE SCIENCES